mRNA |
BRD-K41597374 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.04 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.05 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.05 |
mRNA |
BRD1812 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.05 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.05 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.05 |
mRNA |
GW843682X |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.05 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.05 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.06 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.06 |